M&A Deal Summary

Veracyte Acquires Allegro Diagnostics

On September 4, 2014, Veracyte acquired healthcare services company Allegro Diagnostics for 21M USD

Acquisition Highlights
  • This is Veracyte’s 1st transaction in the Healthcare Services sector.
  • This is Veracyte’s 4th largest (disclosed) transaction.
  • This is Veracyte’s 1st transaction in the United States.
  • This is Veracyte’s 1st transaction in Massachusetts.

M&A Deal Summary

Date 2014-09-04
Target Allegro Diagnostics
Sector Healthcare Services
Buyer(s) Veracyte
Deal Type Add-on Acquisition
Deal Value 21M USD

Target

Allegro Diagnostics

Maynard, Massachusetts, United States
Allegro Diagnostics Corp. focused on developing genomic tests to improve the preoperative diagnosis of lung cancer.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Veracyte

South San Francisco, California, United States

Category Company
Founded 2006
Sector Life Science
Employees815
Revenue 361M USD (2023)
DESCRIPTION

Veracyte is a molecular cytology company. Veracyte seeks to use molecular cytology to improve diagnosis with the promise to help physicians and patients make more informed treatment decisions. Veracyte solution will utilize molecular biomarkers on cytology samples to characterize nodules as benign or suspicious of malignancy. Veracyte was founded in 2006 and is based in South San Francisco, California.


DEAL STATS #
Overall 1 of 4
Sector (Healthcare Services) 1 of 1
Type (Add-on Acquisition) 1 of 4
State (Massachusetts) 1 of 1
Country (United States) 1 of 3
Year (2014) 1 of 1
Size (of disclosed) 4 of 4
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-02-03 Decipher Biosciences

San Diego, California, United States

Decipher Biosciences, Inc. is a commercial-stage precision oncology company committed to improving patient care, initially focused on urologic cancers. Decipher Biosciences is based in San Diego, California.

Buy $600M